The University of Miami Sylvester Comprehensive Cancer Center has opened a phase I clinical trial of a novel combination therapy for patients with certain types of leukemia and lymphoma. “The idea of this trial is to use an antibody which has had some success in the treatment of these disorders, but to try and augment the effects of that antibody in combination with Interleukin-2,” said Joseph D. Rosenblatt, M.D., associate director, clinical and translational research, UM/Sylvester.
Inadequate access to cancer screening and care is the number one cancer issue for the nation’s 38 million Hispanics/Latinos, according to a report recently issued by Redes En Acción: The National Hispanic/Latino Cancer Network. The Southeast region is headquartered at the University of Miami Sylvester Comprehensive Cancer Center.
Hundreds came out on Saturday, June 5 to Help “Beach” Breast Cancer – the 4th Annual Joan G. Gaines Breast Cancer Fundraiser. All proceeds benefited the Braman Family Breast Cancer Institute at the University of Miami Sylvester Comprehensive Cancer Center.